Expert Insights: Advancing Infusion Care Through Access and Innovation

Hear from our experts on how smarter scheduling and technology strengthen patient experience in health system infusion centers.

By Prateek Bhatia

Read Time

2 minutes

Prateek Bhatia
VP | GM, Intrafusion

By providing patients with convenient access to the infusion services they need, health systems can improve satisfaction, increase trust, and ultimately, achieve better patient outcomes.

While attending ASHP, Prateek Bhatia, BPharm, PhD, vice president and general manager of Intrafusion at McKesson, spoke with Drug Topics about the patient experience in health system infusion centers, and the vital role that pharmacists play in patient care. Read the full article here: https://www.drugtopics.com/view/pharmacists-can-play-central-role-in-patients-infusion-services-ashp-midyear-2025

Bhatia also spoke with Pharmacy Times about the ways that health systems can improve their infusion care through smarter scheduling, analytics and advancements in technology. Watch the full interview here: https://www.pharmacytimes.com/view/expert-improving-infusion-care-through-smarter-scheduling-and-analytics

Contact our experts today to learn more about partnering with McKesson to achieve more.

Brittany Ulrich, PharmD, CSP, BCBBS, examines how limited distribution drugs and payer requirements push specialty prescriptions outside the organization, eroding visibility into patient outcomes, and how Biologics by McKesson helps health systems expect more when it comes to maintaining care continuity.

Aerial view of a large warehouse complex with loading docks, trucks and intersecting roads.

Case Study: How McKesson’s Winter-Storm Playbook Kept Specialty Drugs Moving

Expect more for the business of pharmacy with a pressure-tested, multi-layered business continuity strategy.

Researcher in a laboratory looks through shelving lined with containers and supplies.

What You Should Know About the CMS Proposed 340B Payment Change

Dr. Andrew Wilson, B.S., Pharm.D., FASHP, reflects on the proposed CY 2027 OPPS rule for several outpatient drugs purchased through the 340B program, and the next phase of specialty drug margin management for the business of pharmacy.

Open laptop beside a stack of tabbed documents in a binder on a desk, with a softly blurred office background.

Top Prescribed Perspectives Reads for August

The top three Prescribed Perspectives articles most read by health systems in August.

Business professionals greet with a handshake in a modern office while colleagues stand nearby during a networking conversation.

Upcoming Event: inSPire 2026

Connect with McKesson at inSPire to help shape the future of specialty pharmacy

Healthcare professional and colleague review information on a tablet in a clinical setting.

Where Does Your Health System Fall on the Specialty and Infusion Growth Journey?

With our assessment, benchmark your progress across the specialty and infusion journey to achieve more for the business of pharmacy.

Expert Insights: Advancing Infusion Care Through Access and Innovation

Related Stories

Related Tags